The first pilot-scale demonstration of the partial nitritation/anammox-hydroxyapatite process to treat the effluent of the anaerobic membrane bioreactor fed with the actual municipal wastewater.

ABSTRACT

Recently, it was reported that for synthetic low-strength wastewater, the excellent nitrogen removal rate (NRR) accompanied with phosphorus removal could be achieved through the partial nitritation/anammox (PNA)-hydroxyapatite (HAP) process. Thus, this research further investigated the performance of the pilot-scale PNA-HAP process treating the effluent of an anaerobic membrane bioreactor (AnMBR) fed with the actual municipal wastewater. The results showed that with the hydraulic retention time of 4.0 h, the influent ammonium concentration ranging from 36.0 to 41.0 mg/L, and the BOD5 ranging from 6.3 to 12.7 mg/L, the average NRR and the nitrogen removal efficiency was 0.13 kg/m3/d and 63.38%, respectively. The specific activity test of sludge confirmed that the PNA process was the main nitrogen metabolism pathway. The effluent nitrate and the BOD5 were almost zero, indicating the existence of denitrification activity in reactor. Given that the oxygenation condition, the heterotrophic organic matter oxidization activity also occurred in reactor. The sludge analysis confirmed the phosphate formation in sludge. Thus, in the reactor, four kinds of biological activities and chemical crystallization occurred harmoniously in sludge. From the mixed liquid volatile suspended solid of 2.4 g/L and the low distribution range of granule size, it was obvious that the sludge had a high dispersity. Based on the well settling ability of sludge during the operation, it was inferred that there was a close bond between biomass and HAP in sludge, which was helpful to enhance the settleability of sludge granule. Besides, the phosphorus-containing sludge was suitable as the fertilizer. In all, this study demonstrated that the PNA-HAP process is an ideal alternative treating the effluent of the AnMBR process in the municipal wastewater treatment.